LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

1.25 22.55

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.23

Max

1.26

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+209.52% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	53M 61M
Iepriekšējā atvēršanas cena	-21.3
Iepriekšējā slēgšanas cena	1.25

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 14. nov. 17:45 UTC

Peļņas

Galvenie tirgus virzītāji

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025. g. 14. nov. 17:31 UTC

Peļņas

Galvenie tirgus virzītāji

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025. g. 14. nov. 16:15 UTC

Galvenie tirgus virzītāji

Scholar Rock Shares Rise on Renewed Apitegromab Hopes

2025. g. 14. nov. 23:56 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

2025. g. 14. nov. 23:02 UTC

Tirgus saruna

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

2025. g. 14. nov. 22:35 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

2025. g. 14. nov. 22:32 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

2025. g. 14. nov. 22:29 UTC

Peļņas

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

2025. g. 14. nov. 22:00 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

2025. g. 14. nov. 21:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 14. nov. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

2025. g. 14. nov. 20:27 UTC

Tirgus saruna

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

2025. g. 14. nov. 20:23 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

2025. g. 14. nov. 20:17 UTC

Iegādes, apvienošanās, pārņemšana

Several State Attorneys General Oppose Railroad Merger -- WSJ

2025. g. 14. nov. 19:29 UTC

Tirgus saruna

Peļņas

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

2025. g. 14. nov. 18:44 UTC

Tirgus saruna

Peļņas

Disney's Growth Now Hinges More on ESPN -- Market Talk

2025. g. 14. nov. 18:27 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 14. nov. 18:27 UTC

Tirgus saruna

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

2025. g. 14. nov. 18:20 UTC

Tirgus saruna

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

2025. g. 14. nov. 17:20 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 14. nov. 17:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2025. g. 14. nov. 17:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 14. nov. 16:51 UTC

Tirgus saruna

Starbucks Gets Holiday Sales Lift -- Market Talk

2025. g. 14. nov. 16:48 UTC

Tirgus saruna

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

2025. g. 14. nov. 16:38 UTC

Tirgus saruna

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

2025. g. 14. nov. 16:30 UTC

Iegādes, apvienošanās, pārņemšana

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

2025. g. 14. nov. 16:28 UTC

Tirgus saruna

Ukraine Strike on Russian Port Lifts Distillates -- Market Talk

2025. g. 14. nov. 15:59 UTC

Tirgus saruna

U.S. Natural Gas Inventories Rise More Than Expected -- Market Talk

2025. g. 14. nov. 15:06 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 14. nov. 15:06 UTC

Tirgus saruna

Dollar Could Benefit From U.K., French Fiscal Concerns -- Market Talk

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

209.52% augšup

Prognoze 12 mēnešiem

Vidējais 3.25 USD 209.52%

Augstākais 3.5 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.